AstraZeneca
This article was originally published in The Tan Sheet
Executive Summary
U.S. Patent & Trademark Office publishes 10 Prilosec OTC trademarks, with varying suffixes: OTC, Fast Action, AC, AP, Heartburn Preventer, Gelcap, Acid Inhibitor, Heartburn Blocker, PM and HB. AstraZeneca has a joint development and marketing deal with Procter & Gamble for an OTC version of omeprazole for heartburn (1"The Tan Sheet" Dec. 22, 1997, p. 2). Net sales of the Rx proton pump inhibitor in 1998 totaled $3.1 bil. A recent Campbell Mithun Esty Health study cited $50 mil. in DTC ad spending on Prilosec, which has been the subject of a new ad campaign (2"The Tan Sheet" July 19, p. 8)
You may also be interested in...
AstraZeneca Prilosec OTC Launch Anticipated For Second Quarter 2001
AstraZeneca's Prilosec proton pump inhibitor is anticipated to reach over-the-counter shelves in the second quarter of 2001.
AstraZeneca Prilosec OTC Launch Anticipated For Second Quarter 2001
AstraZeneca's Prilosec proton pump inhibitor is anticipated to reach over-the-counter shelves in the second quarter of 2001.
AstraZeneca Prilosec OTC Launch Anticipated For Second Quarter 2001
AstraZeneca's Prilosec proton pump inhibitor is anticipated to reach over-the-counter shelves in the second quarter of 2001.